News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Apnimed
NEWS
JOBS
IN THE PRESS
20 Holyoke Street Cambridge MA 02138 US
Visit website
Email Us
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Drug Development
Apnimed Appoints John Yee, MD, MPH, as SVP, Medical Affairs
September 18, 2023
·
4 min read
Drug Development
Apnimed to Present New Data on Investigational Oral Therapies for Obstructive Sleep Apnea at ERS International Congress 2023
September 6, 2023
·
4 min read
Genetown
APNIMED to Participate in Upcoming Investor Conferences in September 2023
August 30, 2023
·
3 min read
Genetown
Fierce Biotech Names Apnimed a 2023 “Fierce 15” Biotech Company
August 28, 2023
·
4 min read
Genetown
APNIMED to Participate in the 43rd Annual Canaccord Genuity Global Growth Conference
August 1, 2023
·
3 min read
Genetown
Apnimed to Participate in the William Blair Virtual Conference: Transitioning Biotech Breakthroughs to Commercial Success
July 12, 2023
·
3 min read
Genetown
Apnimed to Participate in the 2023 BIO International Convention
May 23, 2023
·
3 min read
Drug Development
Apnimed Presented Positive Phase 2b Results on AD109, an Investigational Oral Drug for Obstructive Sleep Apnea, for the First Time at ATS 2023
May 21, 2023
·
7 min read
Drug Development
Apnimed to Present Positive Phase 2b Results on AD109, an Investigational Oral Treatment for Obstructive Sleep Apnea, at ATS 2023
May 15, 2023
·
5 min read
Genetown
Apnimed to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 10, 2023
·
3 min read